Advanced Filters
noise

Carcinoma Clinical Trials

A listing of Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 6,091 clinical trials
T Timiya Nolan, PhD

A QoL Intervention for Young African American Breast Cancer Survivors

The purpose of this two-arm pilot RCT is to evaluate processes and preliminary outcomes of a targeted QOL intervention vs. an attention control among young AA survivors post-treatment for early (I-II) & late (III) stage breast cancer.

18 - 44 years of age Female Phase N/A
A Ashley Lynn Trumbull

Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer

This phase II trial examines transcutaneous electrical nerve stimulation (TENS) in patients with stage I-III breast cancer with chemotherapy induced peripheral neuropathy. TENS is a procedure in which mild electric currents are applied to some areas of the skin to potentially improve neuropathy. This trial may help determine if TENS …

18 years of age All Phase N/A
D Deborah Omoyege

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

This phase I trial tests the safety, side effects, and best dose of a personalized vaccine (tumor membrane vesicle or TMV vaccine) by itself and in combination with checkpoint inhibitor (pembrolizumab or ipilimumab) in treating patients with triple negative breast cancer. This vaccine is made by taking a piece of …

18 years of age All Phase 1
C Cristina Mosconi, MD

Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will …

18 years of age All Phase N/A
F Francesco Fiorio, MSC

Translational Cancer Observational Protocol

Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery

18 years of age All Phase N/A
A Ajay Jain, MD

Identify microRNAs in Cachexia in Pancreatic Carcinoma

The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the genes between patient groups.

18 years of age All Phase N/A
S Sarina Mueller, PD

Immune Biomarker Study for Salivary Gland Carcinoma

Aims of this study are analyses of tumor metabolome, tumor transcriptome and tumor proteome as well as of the immune infiltration, separated by histological entity. These data will subsequently be compared with the with the detailed immune status determined in the patient's peripheral blood and saliva using machine learning techniques, …

18 years of age All Phase N/A
L Landon L CHAN, MBChB, MSc

Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

Radiotherapy is increasingly being used in the management of hepatocellular carcinoma (HCC) as a standalone treatment, or in combination with systemic therapy. Stereotactic Body Radiation Therapy (SBRT) causes cell death directly (via double-stranded breaks) and indirectly (via vascular bed damage or promotion of antitumour immunity). Unfortunately, the effect of cell …

18 years of age All Phase N/A
R Reem Gamal

Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma

The study will evaluate the local experiences in treatment of head and neck carcinoma by retrospectively analyzing the incidence and location of recurrence, and also studying factors affecting this recurrence.

18 years of age All Phase N/A
L Laura Gramantieri, MD

Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma

The study is aimed to test the performance of a simple, easy, reproducible cytofluorimetric assay to complement imaging studies for: predicting response to immune-therapeutic regimens in HCC in the early phase of treatment, to rule out pseudo-progression, to early predict the escape from effectiveness of treatment.

18 years of age All Phase N/A

Simplify language using AI